3-Hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote alpha-crystallin cross-linking by metal ion reduction
- PMID: 10852726
- DOI: 10.1021/bi992997s
3-Hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote alpha-crystallin cross-linking by metal ion reduction
Abstract
The kynurenine pathway catabolite 3-hydroxykynurenine (3HK) and redox-active metals such as copper and iron are implicated in cataractogenesis. Here we investigate the reaction of kynurenine pathway catabolites with copper and iron, as well as interactions with the major lenticular structural proteins, the alpha-crystallins. The o-aminophenol kynurenine catabolites 3HK and 3-hydroxyanthranilic acid (3HAA) reduced Cu(II)>Fe(III) to Cu(I) and Fe(II), respectively, whereas quinolinic acid and the nonphenolic kynurenine catabolites kynurenine and anthranilic acid did not reduce either metal. Both 3HK and 3HAA generated superoxide and hydrogen peroxide in a copper-dependent manner. In addition, 3HK and 3HAA fostered copper-dependent alpha-crystallin cross-linking. 3HK- or 3HAA-modifed alpha-crystallin showed enhanced redox activity in comparison to unmodified alpha-crystallin or ascorbate-modified alpha-crystallin. These data support the possibility that 3HK and 3HAA may be cofactors in the oxidative damage of proteins, such as alpha-crystallin, through interactions with redox-active metals and especially copper. These findings may have relevance for understanding cataractogenesis and other degenerative conditions in which the kynurenine pathway is activated.
Similar articles
-
3-Hydroxykynurenine oxidizes alpha-crystallin: potential role in cataractogenesis.Biochemistry. 2006 Feb 14;45(6):1852-60. doi: 10.1021/bi051737+. Biochemistry. 2006. PMID: 16460031
-
The modification of proteins by 3-hydroxykynurenine.Exp Eye Res. 1993 Aug;57(2):149-55. doi: 10.1006/exer.1993.1110. Exp Eye Res. 1993. PMID: 8405181
-
Changes of lens crystallins photosensitized with tryptophan metabolites.Ophthalmic Res. 1987;19(3):157-63. doi: 10.1159/000265488. Ophthalmic Res. 1987. PMID: 3658326
-
Reactive metabolite hypothesis for human senile cataract.Lens Eye Toxic Res. 1991;8(2-3):251-7. Lens Eye Toxic Res. 1991. PMID: 1911640 Review.
-
An expanding range of targets for kynurenine metabolites of tryptophan.Trends Pharmacol Sci. 2013 Feb;34(2):136-43. doi: 10.1016/j.tips.2012.09.006. Epub 2012 Nov 1. Trends Pharmacol Sci. 2013. PMID: 23123095 Review.
Cited by
-
Targeting the progression of Parkinson's disease.Curr Neuropharmacol. 2009 Mar;7(1):9-36. doi: 10.2174/157015909787602814. Curr Neuropharmacol. 2009. PMID: 19721815 Free PMC article.
-
The kynurenine pathway in adolescent depression: preliminary findings from a proton MR spectroscopy study.Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):37-44. doi: 10.1016/j.pnpbp.2009.09.015. Epub 2009 Sep 21. Prog Neuropsychopharmacol Biol Psychiatry. 2010. PMID: 19778568 Free PMC article.
-
Fathoming the kynurenine pathway in migraine: why understanding the enzymatic cascades is still critically important.Intern Emerg Med. 2015 Jun;10(4):413-21. doi: 10.1007/s11739-015-1208-6. Epub 2015 Feb 24. Intern Emerg Med. 2015. PMID: 25708356 Review.
-
Mechanisms of copper ion mediated Huntington's disease progression.PLoS One. 2007 Mar 28;2(3):e334. doi: 10.1371/journal.pone.0000334. PLoS One. 2007. PMID: 17396163 Free PMC article.
-
Involvement of kynurenines in Huntington's disease and stroke-induced brain damage.J Neural Transm (Vienna). 2012 Feb;119(2):261-74. doi: 10.1007/s00702-011-0676-8. Epub 2011 Jun 22. J Neural Transm (Vienna). 2012. PMID: 21695417 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources